Citadel Advisors’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $234K | Buy |
|
|||||
|
2022
Q3 | $346K | Sell |
|
|||||
|
2022
Q2 | $1.04M | Buy |
|
|||||
|
2022
Q1 | $877K | Sell |
|
|||||
|
2021
Q4 | $2.4M | Buy |
|
|||||
|
2021
Q3 | $3.19M | Sell |
|
|||||
|
2021
Q2 | $6.24M | Sell |
|
|||||
|
2021
Q1 | $13M | Sell |
|
|||||
|
2020
Q4 | $33.6M | Buy |
|
|||||
|
2020
Q3 | $520K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $132K | Buy |
|